p53 and bcl-2 protein expression in non-small-cell lung carcinoma

Diagnostic Cytopathology

Volumn 19, Issue 4, 1998, Pages 255-259

  Athanassiadou, Pauline ^a,d   Dosios, Theodosios ^b   Petrakakou, Efthalia ^a   Liossi, Anna ^a   Zerva, Cherry ^b   Athanassiades, Peter ^c  

^a Private Laboratory   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c ALEXANDRA HOSPITAL   (Greece)

^d UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Bcl 2; Immunocytochemistry; Non small cell lung carcinoma; P53

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER INCIDENCE; CANCER STAGING; DISEASE ASSOCIATION; EARLY DIAGNOSIS; ERADICATION THERAPY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR CLASSIFICATION; TUMOR DIAGNOSIS;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031706315     PISSN: 87551039     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0339(199810)19:4<255::AID-DC5>3.0.CO;2-9     Document Type: Article

References (21)

1. Kennedy MM, Lamb D, King G, Kerr KM. Cell proliferation, cell loss and expression of bcl-2 and p53 in human pulmonary neoplasms. Br J Cancer 1997;75:545-547.
2. Poller DN, Baxter KJ, Shepherd NA. p53 and Rb1 protein expression: are they prognostically useful in colorectal cancer? Br J Cancer 1997;75:87-93.
3. Zusman I. The clinical relevance of p53 oncoprotein determination in cancer diagnosis and prognosis. [Review] Oncol Rep 1995;2:143-150.
4. Baas IO, Mulder JWR, Offerhaus GJA, Vogelstein B, Hamilton SR. Evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in achival colorectal neoplasms. J Pathol 1994;172:5-12.
5. Kastan MB, Onyekwere O, Sidransky D, Volgelstein B, Craig RW. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991;51:6304-6311.
6. Lane DP. p53, guardian of the genome. Nature 1992;358:15-16.
7. Ellis PA, Smith IE, Dowsett M. Apoptosis-its role in tumor growth and therapy. Cytopathology 1996;7:201-203.
8. Culotta E, Koshland DE, Jr. p53 sweeps through cancer research. Science 1993;262:1958-1961.
9. Lane DP. A death in the life of p53. Nature 1993;362:786-787.
10. Harris CC. p53: at the crossroads of molecular carcinogenesis and risk assessment. Science 1993;262:1980-1981.
11. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990;348:334-336.
12. Korsemeyer SJ. Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 1992;80:879-886.
13. Wyllie AH. Apoptosis: recent advances in histopathology. Anthony P, MacSween R, Lowe D, eds. London: Churchill, Livingstone 1997:1-14.
14. Pezzella F, Turley H, Kuzu I, et al. Bcl-2 protein in non-small cell lung carcinoma. N Engl J Med 1993;329:690-694.
15. Hickman JA. Apoptosis induced by anticancer drugs. Cancer Metastasis Rev 1992;11:121-139.
16. Gotz C, Montenarh M. p53 and its implication in apoptosis (Review). Int J Oncol 1995;6:1129-1135.
17. Donehower LA, Harvey M, Slagle BL, et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature 1992;356:215-221.
18. Walker C, Robertson LJ, Myskow MW, Pendleton N, Dixon GR. p53 expression in normal and dysplastic bronchial epithelium and in lung carcinomas. Br J Cancer 1994;70:297-303.
19. Boers JE, ten Velde GP, Thunnissen FB. P53 in squamous metaplasia: a marker for risk of respiratory tract carcinoma. Am J Resp Crit Care Med 1996;153:411-416.
20. Konishi T, Lin Z, Fujino S, Kato H, Mori A. Association of p53 protein expression in stage 1 lung adenocarcinoma with reference to cytological subtypes. Hum Pathol 1997;28:544-548.
21. Levesque MA, Tadross L, Diamandis EP, D'Costa M. Comparison of immunofluorometry and immunohistochemistry for the detection of p53 protein in lung cancer specimens. Am J Clin Pathol 1997;107:308-316.